A comparison of the actions of ICI66082 and propranolol on cardiac and peripheral beta-adrenoceptors
- PMID: 11998
- DOI: 10.1016/0014-2999(75)90227-7
A comparison of the actions of ICI66082 and propranolol on cardiac and peripheral beta-adrenoceptors
Abstract
The relative blocking potencies of ICI66082 and propranolol with respect to heart rate contractility, diastolic blood pressure and peripheral vascular conductance were compared in anaesthetized dogs. Peripheral blood flow was measured with an electromagnetic flow-probe around the descending aorta with retrograde cannulation of the inferior mesenteric artery for intra-arterial injections of isoprenaline. Cardiac and peripheral vascular effects of ICI66082 and propranolol were compared in terms of the shifts in the dose--response curves after i.v. and intra-arterial injections of isoprenaline. Propranolol was twice as potent as an equimolar dose of ICI66082 on cardiac beta-adrenoceptors. It was 70--130 times more potent in its action on the peripheral vascular receptors. Propranolol itself was 3 times more potent in blocking peripheral vascular receptors than cardiac beta-receptors. ICI66082 was 17--21 times more active in blocking the myocardial beta-adrenoceptors than those in the peripheral vessels. Electrophysiological studies showed that ICI66082 is devoid of membrane-depressant properties in concentrations up to 100 mg/l.
Similar articles
-
The ratio of cardiac to vascular beta-receptor blockade of atenolol and propranolol in spontaneously hypertensive rats in vivo.J Pharmacobiodyn. 1982 Sep;5(9):745-7. doi: 10.1248/bpb1978.5.745. J Pharmacobiodyn. 1982. PMID: 6296350
-
Cardiospecificity of -receptor blockade. A comparison of the relative potencies on cardiac and peripheral vascular -adrenoceptors of propranolol, of practolol and its ortho-substituted isomer, and of oxprenolol and its para-substituted isomer.Cardiovasc Res. 1973 Mar;7(2):226-40. doi: 10.1093/cvr/7.2.226. Cardiovasc Res. 1973. PMID: 4144352 No abstract available.
-
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):681-4. Br J Clin Pharmacol. 1976. PMID: 10948 Review.
-
Characterization of the beta-adrenoreceptors which mediate the isoprenaline-induced changes in finger tremor and cardiovascular function in man.Eur J Clin Pharmacol. 1988;35(5):507-14. doi: 10.1007/BF00558246. Eur J Clin Pharmacol. 1988. PMID: 2853055 Clinical Trial.
-
Myocardial adrenoceptors and cardiac arrhythmias.Pharmacol Res Commun. 1978 Jul;10(7):573-88. doi: 10.1016/s0031-6989(78)80001-0. Pharmacol Res Commun. 1978. PMID: 30982 Review. No abstract available.
Cited by
-
Beta-blockers and asthma.Br Heart J. 1978 Feb;40(2):184-9. doi: 10.1136/hrt.40.2.184. Br Heart J. 1978. PMID: 25075 Free PMC article. Clinical Trial.
-
Beta-blockers in patients without heart failure after myocardial infarction.Cochrane Database Syst Rev. 2021 Nov 5;11(11):CD012565. doi: 10.1002/14651858.CD012565.pub2. Cochrane Database Syst Rev. 2021. PMID: 34739733 Free PMC article.
-
Effects of para-substituted beta-adrenoceptor blocking agents and methyl-substituted phenoxypropanolamine derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles.Naunyn Schmiedebergs Arch Pharmacol. 1985 Mar;329(1):77-85. doi: 10.1007/BF00695196. Naunyn Schmiedebergs Arch Pharmacol. 1985. PMID: 2582279
-
Effect of beta-adrenergic blockade on blood pressure variation in patients with moderate hypertension.Eur J Clin Pharmacol. 1977;11(5):325-7. doi: 10.1007/BF00566528. Eur J Clin Pharmacol. 1977. PMID: 880971 Clinical Trial.
-
Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.Drugs. 1979 Jun;17(6):425-60. doi: 10.2165/00003495-197917060-00001. Drugs. 1979. PMID: 38096 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources